Viral and cellular biomarkers used for improving prevention and management of cervical cancer
| Autor: | Ana Maria Alexandra Stănescu, Anca A. Simionescu, Pharmacy, Bucharest, Romania, Manuela C. Russu, Şerban Nastasia, Ana-Cătălina Savu, Anca Popa |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Romanian Journal of Medical Practice, Vol 16, Iss 2, Pp 123-126 (2021) |
| ISSN: | 2069-6108 1842-8258 |
| DOI: | 10.37897/rjmp.2021.2.2 |
| Popis: | Cervical cancer remains one of the preventable cause of women’s death, the second most common cause of death in Europe. Several screening tests for precancerous lesions are available, including cervicovaginal cytology and screening of high-risk human papillomavirus (HPV) strains – 16, 18, 31, 33. Cervical cytology (Babeş-Papanicolau smear test) remains the elected method for cervical cancer screening in many countries. Last decades, HPV DNA sequence was identified, including gene number and encoded proteins. HPV DNA gene expression involves the use of multiple promoters and complex patterns of splicing, which served as a model for the elaboration of cellular and molecular biomarkers for the identification. Herein, we present the usefulness and efficiency of viral and cellular biomarkers in improving the diagnosis and managing precursor lesions of cervical cancer. Viral and cellular biomarkers can help differentiating low-grade lesion leading to a better diagnosis. HPV DNA tests, although a primary screening method in actual guidelines, can serve as a better screening test method. Other viral biomarkers that include E6 and E7 mRNA testing and determining the methylation of viral genes have good test screening results. Cellular biomarkers such as the immunocytochemical staining of p16INK4a, alone or combined with the proliferation marker Ki-67, can reveal anomalies in the cell cycle. The E4 protein, strongly expressed in productive infections, can prove a transforming infection when it is absent. In recent years, detection of the TERC gene and oncogenetic microRNAs expressed early in carcinogenesis before clinical findings show great promise in differentiating lesions likely to progress to cancer. In conclusion, biomarkers are more powerful instruments to enhance early pre-cervical cancer lesions diagnosis, which allow better prognosis and more reliable treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|